Skip to content
★ Sign in to follow
BI

Biovica Stock: price and insider trades · Sweden

Biovica: what insiders have been doing

We have very little insider data for Biovica so far: the most recent filing dates from 6 April 2018. With so few records, no pattern can be drawn yet. Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.

Insider Decl.
3
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a

Financial data

· cache

Last declaration on 6 April 2018
Declarations3 total
  • ●
    VP Clinical DevelopmentExecutives
    0FI-SE
    106,560 shares0FI:csv-8ef008c8321be52a2776
  • ●
    VP Clinical DevelopmentExecutives
    0FI-SE
    106,560 shares0FI:csv-42960d2018e05ebab633
  • ●
    VP Clinical DevelopmentExecutives
    1M SEK19FI-SE
    106,560 shares@ SEK 11.15100.0% of flowFI:csv-d2d7b005264773cc03ee

3 of 3 declarations

About Biovica

Biovica is a company focused on developing diagnostic tests for cancer, aiming to enhance patient monitoring. It is listed on the Stockholm Stock Exchange (XSTO).

Recent ranked signals on the same market

Purchases our model currently ranks for the recommendations list.

All recommendations